BCCIP and laryngeal carcinoma: Downregulation of BCCIP expression has been reported in brain cancer, laryngeal cancer, ovarian cancer, renal cell carcinoma, colorectal cancer, and recently among hepatocellular carcinoma [12, 25, 29, 38–40].